Workflow
Accuray(ARAY)
icon
Search documents
3 Penny Stock Lotto Tickets With 100X Potential
Investor Place· 2024-07-10 10:22
When it comes to investing in top penny stocks, a word of caution.Always do your due diligence before buying. Make sure it has volume. Know upfront that you can lose a lot of money. And don’t get caught up in the promotional promises of turning $10,000 into millions without first doing your homework. As I’ll repeat below, penny stocks are frequently the playground for scam artists and market manipulators.Sure, some penny stocks turned out to be massive success stories, like Apple (NASDAQ:AAPL), Ford (NYSE:F ...
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
Prnewswire· 2024-06-27 11:35
The Radixact System will be supplied with ClearRT®, Synchrony®, and the VOLO™ Ultra Optimizer to enhance radiation treatment delivery precision and speedHeidelberg University Hospital is recognized worldwide for excellence in patient care and practice changing researchMADISON, Wis., June 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company's Radixact® System, equipped with its prop ...
Accuray (ARAY), TrueNorth Unite to Aid Radiation Departments
ZACKS· 2024-06-24 15:50
Accuray Incorporated (ARAY) recently announced an agreement with TrueNorth Medical Physics LLC, a private company offering radiation oncology consultancy to radiation oncology departments external help aimed to improve the capabilities of the departments.Under the terms of the agreement, TrueNorth is likely to offer services that are complementary and supplementary to the services provided by Accuray, acting as an extension of the hospital team. This will enable hospitals to ensure that it has the staffing ...
Accuray and TrueNorth Medical Physics Sign Agreement to Provide Radiation Oncology Support Intended to Advance Cancer Care for More Patients
Prnewswire· 2024-06-20 11:35
MADISON, Wis., June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities. Under the terms of the agreement, TrueNorth Medical Physics will offer services that are complementary and supplementary to those supplied by Accuray, acting as an extension of the hospital team – on-site, remote or hybrid – to help ensure they ha ...
Accuray's (ARAY) Precision TPS Gets Approved by China's NMPA
ZACKS· 2024-06-13 16:37
Accuray Incorporated (ARAY) recently announced that the Chinese National Medical Products Administration (NMPA) approved the registration dossier of the Accuray Precision Treatment Planning System (TPS).The CNNC-Accuray joint venture Tomo C radiation therapy system and the Accuray Precision TPS are now compatible. These are likely to provide medical teams with a new way to administer highly accurate and precise radiation treatments, as well as expand access to care for more cancer patients in China.More on ...
Accuray Announces Approval of the Accuray Precision® Treatment Planning System by China's National Medical Products Administration
Prnewswire· 2024-06-12 11:35
MADISON, Wis., June 12, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the registration dossier for the Accuray Precision® Treatment Planning System (TPS) has been approved by the Chinese National Medical Products Administration (NMPA). The Accuray Precision TPS is now available for use with the CNNC-Accuray joint venture Tomo® C radiation therapy system and in combination, will provide medical care teams with a new option for delivering extremely precise and accurate radiothe ...
New Strong Sell Stocks for May 24th
zacks.com· 2024-05-24 11:51
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:3D Systems Corporation (DDD) is 3D printing solutions company. The Zacks Consensus Estimate for its current year earnings has been revised 11.1% downward over the last 60 days.Accuray Incorporated (ARAY) is a radiation oncology company. The Zacks Consensus Estimate for its current year earnings has been revised 128.6% downward over the last 60 days.Brenntag SE (BNTGY) is a chemical distribution company.The Zacks Consensus Estimate for ...
Accuray to Participate in the Jefferies Global Healthcare Conference 2024
prnewswire.com· 2024-05-22 20:30
MADISON, Wis., May 22, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024. The management team is scheduled to participate in a fireside chat on Wednesday, June 5, 2024 at 7:30am EDT/4:30am PDTA live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available for 90 days.About ...
Accuray(ARAY) - 2024 Q3 - Quarterly Report
2024-05-08 20:22
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value per share ARAY The Nasdaq Stock Market LLC FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission F ...
Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts
Zacks Investment Research· 2024-05-02 14:21
Accuray Incorporated (ARAY) reported a loss per share of 6 cents for the third quarter of fiscal 2024 against the year-ago period’s earnings per share (EPS) of a penny. The metric was also wider than the Zacks Consensus Estimate of a loss of a penny per share.Revenues in DetailAccuray registered revenues of $101.1 million in the third quarter of fiscal 2024, down 14.3% year over year. The figure lagged the Zacks Consensus Estimate by 11.8%.The overall top-line growth was dampened by lower revenues from both ...